The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,796,567 in first-year total cost, median $777,971.
Most frequent study sections
- Special Emphasis Panel[ZRG1 CCHI-M (56)]10
Most frequent institutions
- DUKE UNIVERSITY1
- FRED HUTCHINSON CANCER CENTER1
- MEDICAL UNIVERSITY OF SOUTH CAROLINA1
- SEATTLE INST FOR BIOMEDICAL/CLINICAL RES1
- TEMPLE UNIV OF THE COMMONWEALTH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Leveraging Pharmacy Technicians to Advance the Reach of Modern Antiretroviral Therapy (PHARM ART) in Community Clinics1R01MH140440-01 | CHRISTOPOULOS, KATERINA AMCNULTY, MOIRA | UNIVERSITY OF CHICAGO, IL | $1,583,791 | ZRG1 |
| 2025 | A ProgramPharmacy Chains to Increase PrEP Awareness and Access Among Men1R01AI191576-01 | KANAMORI NISHIMURA, MARIANO JUAN | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $1,066,077 | ZRG1 |
| 2025 | Pharmacists for Prevention (P4P): Harnessing the role of pharmacists in ending the HIV epidemic through collaboration with pharmacy schools1R01AI191573-01 | BOSWORTH, HAYDEN BOKEKE, NWORA LANCEWARE, KENRIC | DUKE UNIVERSITY, NC | $962,973 | ZRG1 |
| 2025 | Optimizing Medications and Lung Health in People with HIV through Pharmacist-led Proactive E-Consults (OPTIMIZE Lung-HIV)1R01HL179905-01 | CROTHERS, KRISTINA ANNEKUNISAKI, KEN M.VARDENY, ORLY | SEATTLE INST FOR BIOMEDICAL/CLINICAL RES, WA | $803,801 | ZRG1 |
| 2025 | Advancing pharmacy-based delivery of primary STI and HIV prevention for cisgender women1R01HD118713-01 | BUKUSI, ELIZABETH ANNEPINTYE, JILLIAN | UNIVERSITY OF WASHINGTON, WA | $793,462 | ZRG1 |
| 2025 | Integrated HIV and Overdose Prevention in Pharmacies: Assessing Availability and Implementation Strategies in Different Policy Environments (HIP-Pharm)1R01DA063269-01 | EGAN, KATHLEEN LOUISELANCASTER, KATHRYN ELIZABETH | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $762,479 | ZRG1 |
| 2025 | Leveraging telehealth to optimize PrEP and PEP delivery at pharmacies in Kenya1R01MH140465-01 | BUKUSI, ELIZABETH ANNEORTBLAD, KATRINA FRANCES | FRED HUTCHINSON CANCER CENTER, WA | $729,286 | ZRG1 |
| 2025 | Tobacco Treatment Specialist Training for Clinical Pharmacists to Advance Service Delivery for People Living with HIV1R01HL180298-01 | ROJEWSKI, ALANASTERBA, KATHERINE REGAN | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $630,139 | ZRG1 |
| 2025 | INTEGRATE RX: Integrating Clinical Pharmacists in HIV care to Mitigate Last-Mile Challenges and Reduce Cardiovascular Disease Burden1R01HL179904-01 | NJUGUNA, BENSON NG'ANG'ATRAN, DAN NGUYEN KHANH | TEMPLE UNIV OF THE COMMONWEALTH, PA | $312,005 | ZRG1 |
| 2025 | Translating Evidence into Action: Novel modeling approaches to understand the efficacy of pharmacy-based PrEP1R01AI191569-01 | FAYAZ FARKHAD, BITA | UNIVERSITY OF PENNSYLVANIA, PA | $152,554 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.